Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, ...

The convergent inputs to the central projection of the trigeminovascular system, the trigeminal nucleus caudalis and the C1 and C2 regions of the spinal cord, collectively known as the ...

NeuroOne announced today that it accelerated the anticipated timeline of the FDA submission for its nerve ablation tech.

“Building on the success of our three product families that have already achieved 510(k) FDA clearance, we have accelerated our submission timeline for the OneRF Trigeminal Nerve Ablation System ...

(RTTNews) - NeuroOne Medical Technologies Corp. (NMTC), Tuesday announced that it has accelerated the timeline for its 510(k) submission to the FDA for the OneRFTrigeminal Nerve Ablation System.